CN105399790B - 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 - Google Patents
一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 Download PDFInfo
- Publication number
- CN105399790B CN105399790B CN201510717053.XA CN201510717053A CN105399790B CN 105399790 B CN105399790 B CN 105399790B CN 201510717053 A CN201510717053 A CN 201510717053A CN 105399790 B CN105399790 B CN 105399790B
- Authority
- CN
- China
- Prior art keywords
- ketone
- ether
- androstene
- carboxylic acid
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 title claims abstract description 29
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title claims abstract description 20
- 238000010189 synthetic method Methods 0.000 title claims abstract description 17
- IATKKATWPOVYCC-VMXHOPILSA-N (8s,9s,10r,13s,14s)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 IATKKATWPOVYCC-VMXHOPILSA-N 0.000 title abstract 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 239000004593 Epoxy Substances 0.000 claims abstract description 11
- 125000004494 ethyl ester group Chemical group 0.000 claims abstract description 10
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical class CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000007062 hydrolysis Effects 0.000 claims abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 4
- 238000006114 decarboxylation reaction Methods 0.000 claims abstract description 3
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 3
- 239000002904 solvent Substances 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 19
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 239000007800 oxidant agent Substances 0.000 claims description 9
- 230000001590 oxidative effect Effects 0.000 claims description 9
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 8
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical group [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 6
- 229960002218 sodium chlorite Drugs 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 5
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 4
- 238000007254 oxidation reaction Methods 0.000 claims description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 2
- 239000012065 filter cake Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 2
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- -1 sodium alkoxide Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 150000001299 aldehydes Chemical class 0.000 abstract description 7
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000007423 decrease Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- NYGWTZLABYSHOP-FCYODTKKSA-N (8R,9S,10S,13R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12-decahydro-1H-cyclopenta[a]phenanthrene Chemical compound C([C@H]12)CC3CCCC[C@]3(C)[C@H]1CC[C@@]1(C)C2=CC=C1 NYGWTZLABYSHOP-FCYODTKKSA-N 0.000 abstract 4
- 150000002576 ketones Chemical class 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000004360 Dioscorea zingiberensis Nutrition 0.000 description 3
- 241001678283 Dioscorea zingiberensis Species 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960004199 dutasteride Drugs 0.000 description 2
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510717053.XA CN105399790B (zh) | 2015-10-28 | 2015-10-28 | 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510717053.XA CN105399790B (zh) | 2015-10-28 | 2015-10-28 | 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105399790A CN105399790A (zh) | 2016-03-16 |
CN105399790B true CN105399790B (zh) | 2017-03-08 |
Family
ID=55465585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510717053.XA Active CN105399790B (zh) | 2015-10-28 | 2015-10-28 | 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105399790B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3875464A1 (en) * | 2020-03-06 | 2021-09-08 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the purification of etiocholenic acid |
CN113943340A (zh) * | 2021-11-15 | 2022-01-18 | 湖南科瑞生物制药股份有限公司 | 一种4-氮杂甾体化合物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917829A (en) * | 1971-11-08 | 1975-11-04 | Research Corp | Novel methods of inhibiting the activity of testosterone 5{60 -reductase |
CN101974052A (zh) * | 2010-11-29 | 2011-02-16 | 台州市信友医药化工有限公司 | 一种雄甾-3-酮-4-烯-17β羧酸的合成方法 |
CN104262442A (zh) * | 2014-10-10 | 2015-01-07 | 湖南科瑞生物科技有限公司 | 黄体酮的制备方法 |
-
2015
- 2015-10-28 CN CN201510717053.XA patent/CN105399790B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3917829A (en) * | 1971-11-08 | 1975-11-04 | Research Corp | Novel methods of inhibiting the activity of testosterone 5{60 -reductase |
CN101974052A (zh) * | 2010-11-29 | 2011-02-16 | 台州市信友医药化工有限公司 | 一种雄甾-3-酮-4-烯-17β羧酸的合成方法 |
CN104262442A (zh) * | 2014-10-10 | 2015-01-07 | 湖南科瑞生物科技有限公司 | 黄体酮的制备方法 |
Non-Patent Citations (2)
Title |
---|
"Azasteroids: structure-activity relationships for inhibition of 5α-reductase and of androgen receptor binding";Gary H.Rasmusson et al.;《Journal of Medicinal Chemistry》;19861231;第29卷(第11期);第2298-2315页 * |
"Synthesis of 4-trifluoromethylsteroids: a novel class of steroid 5α-reductase inhibitors";Xiang-Shu Fei et al.;《Bioorganic & Medicinal Chemistry Letters》;19971231;第7卷(第24期);第3113-3118页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105399790A (zh) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105399791B (zh) | 一种倍他米松中间体的制备方法 | |
CN103319560A (zh) | 一种熊去氧胆酸的制备方法 | |
CN105218610B (zh) | 一种以豆甾醇降解物为原料合成胆固醇的方法 | |
CN105399790B (zh) | 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 | |
CN104327150B (zh) | 一种螺内酯中间体坎利酮的合成方法 | |
CN106397519A (zh) | 一种烯丙孕素的制备方法 | |
EP4116314A1 (en) | Method for preparing 16alpha-hydroxyprednisolone | |
CN105593236B (zh) | 用于合成醋酸乌利司他及其4′‑乙酰基类似物的工业化方法 | |
CN1282744A (zh) | 糠酸莫米松的制备方法 | |
CN102443038A (zh) | 化合物6β,19β-环氧-4-雄甾烯-3,17-二酮的制备方法 | |
CN114315942B (zh) | 一种雌酚酮的合成方法 | |
CN104072564A (zh) | 2β,3α,5α-三羟基-雄甾-6-酮及其制备方法与用途 | |
CN100436474C (zh) | 胆甾-3β,5α,6β,19-四羟基-24-酮及其衍生物的合成方法 | |
CN106995478A (zh) | 一种熊去氧胆酸的中间体7‑酮基石胆酸的合成方法 | |
CN108203455B (zh) | 一种双氢非那雄胺碘化物脱碘制备非那雄胺的方法 | |
RU2246500C1 (ru) | Способ получения бетулиновой кислоты | |
CN107176965B (zh) | 一种合成醋酸阿比特龙新方法 | |
CN108047296B (zh) | 一种倍他米松中间体的制备方法 | |
CN110862430A (zh) | 一种5α-雄甾烷-3,17-二酮的制备方法 | |
CN104788529B (zh) | 5α-氯-雄甾-6β,19-环氧-3,17-二酮的制备方法 | |
CN109134571A (zh) | 一种17-碘-雄甾-5,16-二烯-3β-醇的制备方法 | |
CN107619424A (zh) | 一种17‑羟基腈甾体衍生物的制备方法 | |
CN103467270B (zh) | 一种3-氧代环丁烷羧酸的制备方法 | |
CN110256519A (zh) | 一锅法制备醋酸乌利司他的方法 | |
CN105461776B (zh) | 一种黄体酮的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis of 3-keto-4-androstene-17 b - carboxylic acid Effective date of registration: 20200928 Granted publication date: 20170308 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230131 Granted publication date: 20170308 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A 3-keto-4-androsten-17 b The synthesis method of carboxylic acid Granted publication date: 20170308 Pledgee: Industrial and Commercial Bank of China Limited Shaoyang Beita Branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980006163 |